 |
Custom assay development and validation
|
|
|
 |
Assay transfer
|
|
|
 |
Support to first time in man studies (FTM) with agreed fast turnaround of data
|
|
|
 |
Support to Phase I – IV including proof of concept (PoC) and bioequivalence studies.
|
|
|
 |
Short time from study end to report
|
|
|
 |
Non-compartmental PK analysis
|
|
|
 |
Flexible reporting to meet the client’s specific requirements
|
|
|